Nursing care
Why does heparin cause thrombocytopenia? How HIT antibodies drop platelets and form clots
Written and reviewed by Nicole Ramirez, BSN, RN, CMSRN · 4 min read · Updated November 2026
Short answer
Heparin causes thrombocytopenia (HIT) when the immune system makes IgG antibodies against complexes of heparin bound to platelet factor 4 (PF4). These antibodies latch onto platelets and activate them, so platelets are used up and the count falls. The activated platelets also drive clot formation, which is why HIT causes thrombosis rather than bleeding.
The antibody chain reaction
Platelets store a protein called platelet factor 4. When heparin is in the blood, PF4 and heparin bind into large complexes that the immune system can mistake for something foreign. The ASH 2018 guideline describes HIT as caused by IgG antibodies that target these PF4 and heparin complexes.
Once formed, the antibodies bind complexes sitting on platelet surfaces and switch those platelets on. ASH explains that this creates a hypercoagulable state through platelet activation and the release of procoagulant particles. Activated platelets are consumed and cleared, so the count drops. MSD Manuals reports HIT in up to 2.4 percent of clients receiving unfractionated heparin.
When HIT occurs, and why the timing matters
Making new IgG antibodies takes time, so the typical platelet fall begins about 5 to 14 days after heparin is started, according to ASH. A client who received heparin within roughly the last 30 days may already carry antibodies, and in that case the count can fall within hours of re-exposure.
That timing shapes monitoring. ASH suggests platelet counts from day 4 to day 14 for at-risk clients with no recent heparin, and from day 0 when heparin was given in the previous 30 days. MSD Manuals advises stopping heparin when the count falls by more than 50 percent or a new clot appears with a low count. Exposure does not need to be large: MSD Manuals notes HIT can follow the small amounts in line flushes.
Why HIT causes clots rather than bleeding
Students expect a low platelet count to mean bleeding, and that instinct fails here. MSD Manuals states that bleeding is uncommon in HIT, while paradoxical arterial and venous thromboses are the main danger and can be life threatening. The platelets are not missing because of poor production; they are being activated into clots.
So the assessment focus is new clotting. A swollen, painful calf suggests deep vein thrombosis, sudden shortness of breath or chest pain suggests pulmonary embolism, and a cold, pale or pulseless limb suggests an arterial clot. These findings in a client on heparin with a falling count need prompt reporting, and the linked comparison page shows how this differs from DIC.
Nursing actions when HIT is suspected
Stopping heparin means all heparin, including flushes. MSD Manuals and ASH both describe moving to a non-heparin anticoagulant such as argatroban, bivalirudin or fondaparinux, because the clotting risk persists after heparin stops. Switching to enoxaparin is not a safe substitute: MSD Manuals notes that most HIT antibodies cross-react with low molecular weight heparin.
Two more points come up often. ASH recommends against starting warfarin until the platelet count has recovered, usually to 150 × 10^9/L or higher, and suggests against routine platelet transfusion in clients who are not at high bleeding risk. The heparin sensitivity is then recorded in the allergy and adverse reaction record under local policy so it is not reordered.
Hypothetical practice scenario
Hypothetical scenario, not a real exam item: on postoperative day 7, a client on unfractionated heparin has a platelet count that has fallen from 240,000 to 105,000 per microliter, and the left calf is newly swollen and tender. Options: switch the order to enoxaparin, request a platelet transfusion, or stop all heparin including flushes and notify the prescriber.
Stopping all heparin and notifying the prescriber is the right first move. The timing and a fall of more than half point to HIT, and the calf suggests a new clot. Enoxaparin sounds like a gentler heparin, yet the antibodies usually cross-react with it. A platelet transfusion treats the number, not the clotting process driving it.
Sources and further reading
MSD Manual Professional Version: Thrombocytopenia: Other Causes (heparin-induced thrombocytopenia). Incidence up to 2.4 percent with unfractionated heparin, HIT from flush doses, thrombosis rather than bleeding, stop heparin at a fall over 50 percent, non-heparin alternatives, LMWH cross-reactivity, delay warfarin.
American Society of Hematology 2018 guidelines: heparin-induced thrombocytopenia (Blood Advances). IgG antibodies to PF4 and heparin complexes, platelet activation and hypercoagulability, 5 to 14 day onset, rapid onset after exposure in prior 30 days, monitoring windows, warfarin after platelet recovery to 150, no routine platelet transfusion.
The next step on this is the same as on everything else here: answer questions and read the rationales. Our pharmacology practice questions are the closest set to what this page covers.
One question from the pharmacology set
A client with heart failure is started on furosemide 40 mg PO daily. Which findings should the nurse report to the provider before administering the next dose? Select all that apply.
Rationale
Furosemide is a loop diuretic, so the two things you are watching are potassium and kidney function. A potassium of 2.9 mEq/L is below the 3.5–5.0 reference range and puts the client at risk for dysrhythmia — hold and report. Muscle cramps with palpitations are the clinical face of that same hypokalemia, so they are reported together, not separately. A creatinine that doubles signals the diuresis has outrun renal perfusion. A blood pressure of 132/78 and a 1 kg loss are the expected response to the drug working, not reasons to hold it.
Answer: A, D, E
Common questions
When does HIT occur?
Usually 5 to 14 days after heparin is started, the time needed to make new antibodies. If heparin was given in about the last 30 days, the platelet count can fall within hours of restarting it.
Why does HIT cause clots rather than bleeding?
The antibodies activate platelets instead of destroying them quietly. Activated platelets drive clot formation in veins and arteries, so the count falls while clotting risk rises. Bleeding is uncommon in HIT.
Can a client with HIT receive enoxaparin?
No. Enoxaparin is a low molecular weight heparin, and most HIT antibodies cross-react with it. A non-heparin anticoagulant such as argatroban, bivalirudin or fondaparinux is used instead, as ordered.
More on pharmacology
Guides on this